We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Adeno-Associated Virus Services for Gene Delivery
Product News

Adeno-Associated Virus Services for Gene Delivery

Adeno-Associated Virus Services for Gene Delivery
Product News

Adeno-Associated Virus Services for Gene Delivery


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Adeno-Associated Virus Services for Gene Delivery"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO has introduced an expanded range of Adeno-associated virus (AAV) cloning and packaging services.

Adeno-associated viruses are single-stranded DNA viruses that can infect a broad range of cell types including dividing and non-dividing cells and are, therefore, widely used vehicles for gene delivery. Clinical trials have not only found AAV to be consistently safe and stable, but their vectors are capable of causing long-term expression in human cells.

Therefore, AAV vectors have many advantages that many other vectors do not. To date, recombinant AAV (rAAV) vectors have been used in many clinical trials in gene therapy, and have achieved promising results from Phase 1 and Phase 2 trials.

AMSBIO offers the highest quality rAAV vectors and the most complete AAV Expression Systems that can be used to express shRNA, or human ORF. Through proprietary technology and innovative AAV vectors, AMSBIO is able to deliver reliable, reproducible, high purity, high titre viral stock every time.

AMSBIO AAV vectors do not elicit significant immune response in vivo and therefore can be used for in vivo gene deliveries. Working with AMSBIO AAV vectors saves users time and increases their efficiency at a cost-effective price.

AMSBIO has also established a robust and professional AAV packaging service, ranging from the small crude scale to the large purified scale. Drawing upon its considerable experience and expertise AMSBIO is able to provide a platform that suits all users needs when it comes to combining scientific discovery and processing advancements in the field of gene therapy.

With AMSBIO's production system, using AAV as a therapeutic vehicle for a broad range of diseases is now a simple task.

Advertisement